Anti-Slavery and Human Trafficking Statement

Introduction from the CEO

We are committed to combating slavery and human trafficking across our business and supply chains. Exploitation in any form has no place in our operations, and we expect the same high standards from everyone we work with. Our commitment to promoting equality and transparency within our workforce ensures that concerns can be raised without fear of recrimination.

Organisation’s Structure, Business, and Supply Chains

Paramount Medical Solutions is a provider of protective clothing and specialist surgical consumables in the healthcare sector. We are headquartered in East Sussex, UK, and operate with 5 employees. Our supply chains include surgical materials, plastics, tubing, and packaging sourced from the UK, Europe, Turkey, China, and India. Our annual turnover is £2,000,000, and we distribute products across Europe.

We maintain close relationships with long-term suppliers while also onboarding new partners as needed. All suppliers must meet our stringent ethical and operational standards to be part of our supply chain.

Policies on Slavery and Human Trafficking

Our Anti-Slavery and Human Trafficking Policy outlines our commitment to operating with integrity in all business dealings. This policy applies to both our business and our supply chains and is reviewed annually to ensure ongoing relevance and compliance with current laws. We also have a Code of Conduct in place for our suppliers, supported by an audit document to assess adherence. The Code covers key areas such as labour rights, working conditions, and compliance with all anti-slavery legislation.

Due Diligence Processes

We have developed a comprehensive due diligence process to identify and mitigate risks of modern slavery within our supply chains. This includes a due diligence questionnaire for all key suppliers and vetting procedures for new suppliers. Our approach is proactive, with regular monitoring and a robust supplier compliance program.

We use audits, ongoing dialogue, and third-party tools such as the Global Slavery Index. Suppliers in higher-risk regions (China, Turkey, India) undergo enhanced scrutiny.

Risk Areas and Management

We recognize that parts of our supply chain in China, Turkey, and India pose a higher risk. To address this, we have:

• Conducted enhanced vetting and audits for suppliers in higher-risk regions.
• Mapped our supply chain to identify and prioritize risk areas.
• Implemented a permit-to-work system and code of conduct compliance for all suppliers.

We plan to expand these measures to tier-2 suppliers in 2025.

Effectiveness and KPIs

• Supplier vetting: 100% compliance for all new major suppliers.
• Screening: Expanded to cover all major suppliers in 2025.
• Supply chain mapping: Focused on China, Turkey, and India.
• Whistleblowing: No reports raised; reporting continues to be encouraged.
• Training: All staff trained, with ongoing updates.

Training and Capacity Building

Training on modern slavery is a core part of our onboarding. Refresher sessions are offered annually. We also encourage suppliers to train their staff on identifying and mitigating risks.

Future Steps

In 2025, we will:

• Continue vetting all significant suppliers.
• Conduct an on-site inspection of a major supplier in China, Turkey, or India.
• Extend due diligence to tier-2 suppliers in higher-risk regions.

This statement is made in accordance with section 54(1) of the Modern Slavery Act 2015 for the financial year ending December 31, 2024. Approved by the board and reviewed annually.

Rolf Sandor

Managing Director
Paramount Medical Solutions Limited
June 17, 2025